{
  "DOI": "10.1038/ejhg.2012.217",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2012.217",
  "alternative-id": [
    "BFejhg2012217"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Cook-Deegan",
      "given": "Robert",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Conley",
      "given": "John M",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Evans",
      "given": "James P",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vorhaus",
      "given": "Daniel",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2012,
        11,
        14
      ]
    ],
    "date-time": "2012-11-14T11:22:49Z",
    "timestamp": 1352892169000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        6,
        26
      ]
    ],
    "date-time": "2023-06-26T19:52:56Z",
    "timestamp": 1687809176000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        15
      ]
    ],
    "date-time": "2024-01-15T17:16:54Z",
    "timestamp": 1705339014447
  },
  "is-referenced-by-count": 50,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2012,
        11,
        14
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2013,
          6
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2012217.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "585-588",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2012,
        11,
        14
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2012,
        11,
        14
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2013,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "BFejhg2012217_CR1",
      "unstructured": "Myriad Genetics I. Written Comments on Genetic Diagnostic Testing Study (the Statement About One Million Tests is on Page 20; the 3 Percent VUS Rate for US Versus 20 Percent for Europe is Attributed to a Market Research Report Cited on Page 23). Salt Lake City, UT: Written statement supplementing oral testimony to the US Patent and Trademark Office pursuant to Section 27 of the America Invents Act of 2011, 2012; 27."
    },
    {
      "author": "K Davies",
      "key": "BFejhg2012217_CR2",
      "unstructured": "Davies K, White M : Breakthrough: The Race to Find the Breast Cancer Gene. New York: John Wiley, 1996.",
      "volume-title": "Breakthrough: The Race to Find the Breast Cancer Gene",
      "year": "1996"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181d72661",
      "author": "ER Gold",
      "doi-asserted-by": "publisher",
      "first-page": "S39",
      "issue": "4 Suppl",
      "journal-title": "Genet Med",
      "key": "BFejhg2012217_CR3",
      "unstructured": "Gold ER, Carbone J : Myriad genetics: in the eye of the policy storm. Genet Med 2010; 12 (4 Suppl): S39–S70.",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.7551/mitpress/1686.001.0001",
      "author": "S Parthasarathy",
      "doi-asserted-by": "publisher",
      "key": "BFejhg2012217_CR4",
      "unstructured": "Parthasarathy S : Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care. Cambridge, MA: MIT Press, 2007.",
      "volume-title": "Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S1525-1578(10)60444-8",
      "author": "MK Cho",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "J Mol Diagn",
      "key": "BFejhg2012217_CR5",
      "unstructured": "Cho MK, Illangasekare S, Weaver MA, Leonard DG, Merz JF : Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003; 5: 3–8.",
      "volume": "5",
      "year": "2003"
    },
    {
      "key": "BFejhg2012217_CR6",
      "unstructured": "Myriad Genetics I: Form 10-Q: Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended Septembera 30, 2011. Salt Lake City, Utah: Myriad Genetics, Inc., 2011."
    },
    {
      "DOI": "10.1016/j.respol.2005.12.003",
      "author": "MM Hopkins",
      "doi-asserted-by": "publisher",
      "first-page": "355",
      "journal-title": "Res Policy",
      "key": "BFejhg2012217_CR7",
      "unstructured": "Hopkins MM, Nightingale P : Strategic risk management using complementary assets: organizational capabilities and the commercialization of human genetic testing in the UK. Res Policy 2006; 35: 355–374.",
      "volume": "35",
      "year": "2006"
    },
    {
      "key": "BFejhg2012217_CR8",
      "unstructured": "UK Human Genetic Commission: Intellectual Property and DNA Diagnostics. London: Human Genetics Commission, 2010."
    },
    {
      "DOI": "10.1086/521032",
      "author": "DF Easton",
      "doi-asserted-by": "publisher",
      "first-page": "873",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2012217_CR9",
      "unstructured": "Easton DF, Deffenbaugh AM, Pruss D et al: A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 2007; 81: 873–883.",
      "volume": "81",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S1548-5315(11)70558-7",
      "author": "A Eisenbraun",
      "doi-asserted-by": "publisher",
      "first-page": "75",
      "journal-title": "Commun Oncol",
      "key": "BFejhg2012217_CR10",
      "unstructured": "Eisenbraun A, Wenstrup R, Hellerstedt B et al: Hereditary breast and ovarian cancer testing: integration and outcomes within community oncology practices. Commun Oncol 2010; 7: 75–81.",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1002/cncr.24200",
      "author": "MJ Hall",
      "doi-asserted-by": "publisher",
      "first-page": "2222",
      "journal-title": "Cancer",
      "key": "BFejhg2012217_CR11",
      "unstructured": "Hall MJ, Reid JE, Burbidge LA et al: BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 2009; 115: 2222–2233.",
      "volume": "115",
      "year": "2009"
    },
    {
      "author": "JBL Saam",
      "key": "BFejhg2012217_CR12",
      "unstructured": "Saam JBL, Bowles K, Roa B et al: Decline in rate of BRCA1/2 variants of uncertain significance: 2002-2008. 27th Annual Education Conference of the National Society of Genetic Counselors. Los Angeles, CA, 2008.",
      "volume-title": "27th Annual Education Conference of the National Society of Genetic Counselors",
      "year": "2008"
    },
    {
      "DOI": "10.1158/0008-5472.417.65.2",
      "author": "K Wu",
      "doi-asserted-by": "crossref",
      "first-page": "417",
      "journal-title": "Cancer Res",
      "key": "BFejhg2012217_CR13",
      "unstructured": "Wu K, Hinson SR, Ohashi A et al: Functional evaluation and cancer risk assessment of BRCA2 unclassified variants. Cancer Res 2005; 65: 417–426.",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.17226/13297",
      "author": "CM Micheel",
      "doi-asserted-by": "publisher",
      "key": "BFejhg2012217_CR14",
      "unstructured": "Micheel CM, Nass SJ, Omenn GS eds: Evolution of Translational Omics: Lessons Learned and the Path Forward. National Academies Press, 2012.",
      "volume-title": "Evolution of Translational Omics: Lessons Learned and the Path Forward",
      "year": "2012"
    },
    {
      "key": "BFejhg2012217_CR15",
      "unstructured": "National Research Council: Sharing Publication-Related Data and Materials: Responsibilities of Authorship in the Life Sciences. Washington, DC: National Academies Press, 2003."
    },
    {
      "key": "BFejhg2012217_CR16",
      "unstructured": "MutaDATABASE. ‘Participating Laboratories’ and ‘Non-Participating Laboratories’ lists at www.mutadatabase.org and personal communication, Patrick Willems, 18 April 2012; in Willems P ed. MutaDATABASE website Belgium, 2012."
    },
    {
      "DOI": "10.1002/humu.21627",
      "author": "NM Lindor",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2012217_CR17",
      "unstructured": "Lindor NM, Guidugli L, Wang X et al: A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat 2012; 33: 8–21.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1093/annonc/mdq661",
      "author": "P Radice",
      "doi-asserted-by": "publisher",
      "first-page": "i18",
      "issue": "Suppl 1",
      "journal-title": "Ann Oncol",
      "key": "BFejhg2012217_CR18",
      "unstructured": "Radice P, De Summa S, Caleca L, Tommasi S : Unclassified variants in BRCA genes: guidelines for interpretation. Ann Oncol 2011; 22 (Suppl 1): i18–i23.",
      "volume": "22",
      "year": "2011"
    },
    {
      "DOI": "10.2174/157340412799079264",
      "author": "S Tommasi",
      "doi-asserted-by": "publisher",
      "first-page": "30",
      "journal-title": "Curr Women Health Rev",
      "key": "BFejhg2012217_CR19",
      "unstructured": "Tommasi S, De Summa S, Pilato B, Paradiso A : BRCA unclassified variants: how can they be classified? Curr Women Health Rev 2012; 8: 30–37.",
      "volume": "8",
      "year": "2012"
    },
    {
      "key": "BFejhg2012217_CR20",
      "unstructured": "International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication 2010."
    }
  ],
  "reference-count": 20,
  "references-count": 20,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2012217"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The next controversy in genetic testing: clinical data as trade secrets?"
  ],
  "type": "journal-article",
  "volume": "21"
}